Skip to content
APPLICATION ANSWERS · E-2 FIELD GUIDE

How should timing be planned when the E-2 enterprise is a university research spin-off awaiting a technology-transfer licence?

Sources checked:

THE DIRECT ANSWER

Treat the licensing agreement between the university's technology-transfer office and the new U.S. entity as a distinct condition from the E-2 review itself. A licence that has been discussed in principle is different from one that has been executed, and the account must distinguish current rights from proposed licence terms, including any royalty, equity or milestone conditions.

Sequence the licence, the entity formation and the immigration review together

Identify who at the university, such as the responsible technology-transfer office, can confirm the current status of licensing negotiations, and keep a dated record of drafts rather than relying on a verbal understanding. Confirm when the U.S. entity will actually hold enforceable rights to develop the licensed technology, since an E-2 filing prepared before the licence is executed may need to be revisited once final terms are known. Coordinate the technology-transfer timeline, the entity's formation documents and the consular or status process rather than fixing a travel date around an unsigned agreement.

Coordinate the technology licence, enterprise commitments, and immigration submission without claiming the company must already trade. An E-2 investor may be actively investing when the capital is irrevocably committed and exposed to risk. A new enterprise qualifies if it will be real and active; present operations are not required. Verify Canadian citizenship, treaty-national ownership of 50 percent or more, development-and-direction control, and proportional substantiality. Nonmarginality requires present or future capacity to provide more than a minimal living or make a significant economic contribution; projected future capacity should generally be realizable within five years after normal business activity begins. The common sequencing error is treating an unsigned licence or revocable deposit as completed investment.

Hypothetical example: an Ottawa agricultural-sensor researcher forms an American company around a university-owned soil-monitoring patent. Before filing, the founder should settle the licence’s territory, milestones, royalties, and termination rights, then align those terms with entity ownership and committed spending. A product-development budget and hiring forecast may support an active, nonmarginal enterprise even before sales. If negotiations alter equity or refund conditions, counsel should reassess treaty ownership, control, and capital at risk before the planned move.